查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591820

高性能醫用塑膠市場：按類型、應用分類 - 2025-2030 年全球預測

High Performance Medical Plastics Market by Type (Ethylene Tetrafluoroethylene, Fluoropolymers, High Performance Polyamides), Application (Artificial Cornea, Chemical Tanks, Drug Delivery) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年高性能醫用塑膠市場價值為10.5億美元，預計2024年將達到11.7億美元，複合年成長率為11.26%，到2030年將達到22.3億美元。

高性能醫用塑膠 (HPMP) 是專為醫療領域高級應用而設計的專用聚合物，具有生物相容性、耐化學性和耐用性等優異性能。這些材料對於醫療設備、植入、手術器材和診斷設備的生產至關重要，可實現更高的精確度、靈活性和安全標準。隨著對輕質、可消毒和耐化學腐蝕的醫療設備需求的增加，HPMP 已變得至關重要。應用範圍廣泛，包括整形外科、心臟病學、藥物傳輸和人工關節。市場成長的主要驅動力是技術進步、老年人口增加、慢性病發病率增加以及對家庭醫療設備的需求不斷成長。在微創手術和個人化醫療創新的推動下，生物可吸收和電活性聚合物的商機正在迅速增加。然而，嚴格的法規環境、不斷上漲的材料成本和複雜的製造流程等挑戰可能會對成長產生負面影響。原物料價格波動和廣泛的研發要求也是主要限制因素。主要的成長機會在於開發具有增強功能和可自訂性的新型聚合物和複合材料。投資永續營運並將智慧技術整合到設備中可以提高競爭力。回收醫用塑膠的未來進步有可能解決環境影響和成本問題。公司還應該考慮與醫療保健提供者合作，創建價值主導的解決方案。市場的性質反映了技術創新、監管合規性和不斷變化的消費者需求之間的動態相互作用，要求公司將技術與對健康標準和消費者趨勢的敏銳意識結合起來。透過專注於生物分解性塑膠和智慧材料的前沿研究，公司可以利用未滿足的需求和新興趨勢來實現永續的業務成長，同時為改善患者的治療效果做出貢獻。

主要市場統計
基準年[2023] 10.5億美元
預測年份 [2024] 11.7億美元
預測年份 [2030] 22.3億美元
複合年成長率（%） 11.26%

市場動態：快速發展的高性能醫用塑膠市場的關鍵市場洞察

供需的動態交互作用正在改變高性能醫用塑膠市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 隨著全球可支配收入的增加，對醫療保健解決方案的需求不斷增加
    • 對植入先進醫療技術的需求不斷成長
    • 精準醫療、人造器官和智慧吸入器的成長潛力
  • 市場限制因素
    • 原物料價格波動
  • 市場機會
    • 對客製化微創設備的偏好日益成長
    • 外科手術中對機器人支援的需求迅速增加
  • 市場挑戰
    • 擔心手術期間的不良反應

波特五力：駕馭高性能醫用塑膠市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對高性能醫用塑膠市場的影響

外部宏觀環境因素在塑造高性能醫用塑膠市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解高性能醫用塑膠市場的競爭狀況

對高性能醫用塑膠市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣高效能醫用塑膠市場供應商績效評估

FPNV 定位矩陣是評估高性能醫用塑膠市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪高性能醫用塑膠市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，高性能醫用塑膠市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的可支配收入不斷增加，增加了對醫療保健解決方案的需求
      • 對植入先進醫療技術的需求不斷成長
      • 精準醫療、人造器官和智慧吸入器的成長潛力
    • 抑制因素
      • 原物料價格波動
    • 機會
      • 持續偏好客製化微創設備
      • 外科手術中對機器人輔助的需求正在迅速增加
    • 任務
      • 擔心手術副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章高性能醫用塑膠市場：按類型

  • 乙烯-四氟乙烯
  • 氟聚合物
  • 高性能聚醯胺
  • 全氟烷氧基
  • 聚醯胺醯亞胺
  • 聚芳醚酮
  • 聚醚醯亞胺
  • 聚醚酮
  • 聚苯硫

第7章 高性能醫用塑膠市場：依應用分類

  • 人工角膜
  • 化學品罐
  • 藥物輸送
  • 醫療設備和工具
  • 藥品
  • 義肢/植入
  • 分泌瓶
  • 無菌盒
  • 手術室照明
  • 處理系統

第8章北美、南美洲高性能醫用塑膠市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區高性能醫用塑膠市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東、非洲高性能醫用塑膠市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Arkema SA
  • BASF SE
  • Celanese Corporation
  • Compagnie de Saint-Gobain SA
  • Daikin Industries, Ltd.
  • DOMO Chemicals GmbH
  • Ensinger
  • Grindwell Norton Ltd
  • Kuraray Co., Ltd.
  • Mitsubishi Chemical Corporation
  • Raumedic AG
  • Roechling SE & Co. AG
  • Sekisui Chemical Co., Ltd
  • Trelleborg AB
  • Victrex PLC
Product Code: MRR-46132FF7A173

The High Performance Medical Plastics Market was valued at USD 1.05 billion in 2023, expected to reach USD 1.17 billion in 2024, and is projected to grow at a CAGR of 11.26%, to USD 2.23 billion by 2030.

High Performance Medical Plastics (HPMPs) are specialty polymers designed for advanced applications in the medical field, characterized by their superior properties like biocompatibility, chemical resistance, and durability. These materials are crucial for fabricating medical devices, implants, surgical instruments, and diagnostic equipment, allowing for higher precision, flexibility, and safety standards. As the demand for lightweight, sterilizable, and chemically resistant medical devices increases, HPMPs become essential. The applications span orthopedics, cardiology, drug delivery, and prosthetics, among others. The market growth is primarily driven by technological advancements, an increasing geriatric population, rising incidences of chronic diseases, and the growing demand for home healthcare devices. There's a burgeoning opportunity in bioresorbable and electroactive polymers, spurred by innovations in minimally invasive surgery and personalized medicine. However, challenges such as stringent regulatory environments, high costs of materials, and complex manufacturing processes can affect growth adversely. Raw material price volatility and extensive R&D requirements also pose significant limitations. Key growth opportunities lie in developing novel polymers and composites that offer enhanced functionality and customization. Investments in sustainable practices and integrating smart technology into devices can provide a competitive edge. Moving forward, advancing recycling technologies for medical plastics might address both environmental impacts and cost concerns. Businesses should also consider partnerships with healthcare providers to create value-driven solutions. The market's nature reflects a dynamic interplay of innovation, regulatory compliance, and evolving consumer needs, encouraging companies to blend technology with acute awareness of health standards and consumer trends. By focusing on cutting-edge research into biodegradable plastics and smart materials, companies can capitalize on unmet needs and emerging trends, achieving sustainable business growth while contributing to improved patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 1.05 billion
Estimated Year [2024] USD 1.17 billion
Forecast Year [2030] USD 2.23 billion
CAGR (%) 11.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving High Performance Medical Plastics Market

The High Performance Medical Plastics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing need for healthcare solutions with rising disposable income globally
    • Growing demand of advanced medical technology in implants
    • Potential growth attributed to precision medicines, artificial organs and smart inhalers
  • Market Restraints
    • Fluctuation in raw material prices
  • Market Opportunities
    • Ongoing preference for customized minimally invasive devices
    • Surge in need for robotic assistance in surgical operations
  • Market Challenges
    • Concerns over adverse effects upon surgery

Porter's Five Forces: A Strategic Tool for Navigating the High Performance Medical Plastics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the High Performance Medical Plastics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the High Performance Medical Plastics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the High Performance Medical Plastics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the High Performance Medical Plastics Market

A detailed market share analysis in the High Performance Medical Plastics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the High Performance Medical Plastics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the High Performance Medical Plastics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the High Performance Medical Plastics Market

A strategic analysis of the High Performance Medical Plastics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the High Performance Medical Plastics Market, highlighting leading vendors and their innovative profiles. These include Arkema SA, BASF SE, Celanese Corporation, Compagnie de Saint-Gobain S.A., Daikin Industries, Ltd., DOMO Chemicals GmbH, Ensinger, Grindwell Norton Ltd, Kuraray Co., Ltd., Mitsubishi Chemical Corporation, Raumedic AG, Roechling SE & Co. AG, Sekisui Chemical Co., Ltd, Trelleborg AB, and Victrex PLC.

Market Segmentation & Coverage

This research report categorizes the High Performance Medical Plastics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Ethylene Tetrafluoroethylene, Fluoropolymers, High Performance Polyamides, Perfluoroalkoxy, Polyamide-Imide, Polyaryletherketones, Polyetherimide, Polyetherketone, and Polyphenylene Sulfides.
  • Based on Application, market is studied across Artificial Cornea, Chemical Tanks, Drug Delivery, Medical Equipment & Tools, Medical Supplies, Prosthesis & Implants, Secretion Bottles, Sterilizing Boxes, Surgical Theater Luminaries, and Therapeutic System.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing need for healthcare solutions with rising disposable income globally
      • 5.1.1.2. Growing demand of advanced medical technology in implants
      • 5.1.1.3. Potential growth attributed to precision medicines, artificial organs and smart inhalers
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuation in raw material prices
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing preference for customized minimally invasive devices
      • 5.1.3.2. Surge in need for robotic assistance in surgical operations
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over adverse effects upon surgery
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. High Performance Medical Plastics Market, by Type

  • 6.1. Introduction
  • 6.2. Ethylene Tetrafluoroethylene
  • 6.3. Fluoropolymers
  • 6.4. High Performance Polyamides
  • 6.5. Perfluoroalkoxy
  • 6.6. Polyamide-Imide
  • 6.7. Polyaryletherketones
  • 6.8. Polyetherimide
  • 6.9. Polyetherketone
  • 6.10. Polyphenylene Sulfides

7. High Performance Medical Plastics Market, by Application

  • 7.1. Introduction
  • 7.2. Artificial Cornea
  • 7.3. Chemical Tanks
  • 7.4. Drug Delivery
  • 7.5. Medical Equipment & Tools
  • 7.6. Medical Supplies
  • 7.7. Prosthesis & Implants
  • 7.8. Secretion Bottles
  • 7.9. Sterilizing Boxes
  • 7.10. Surgical Theater Luminaries
  • 7.11. Therapeutic System

8. Americas High Performance Medical Plastics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific High Performance Medical Plastics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa High Performance Medical Plastics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Arkema SA
  • 2. BASF SE
  • 3. Celanese Corporation
  • 4. Compagnie de Saint-Gobain S.A.
  • 5. Daikin Industries, Ltd.
  • 6. DOMO Chemicals GmbH
  • 7. Ensinger
  • 8. Grindwell Norton Ltd
  • 9. Kuraray Co., Ltd.
  • 10. Mitsubishi Chemical Corporation
  • 11. Raumedic AG
  • 12. Roechling SE & Co. AG
  • 13. Sekisui Chemical Co., Ltd
  • 14. Trelleborg AB
  • 15. Victrex PLC

LIST OF FIGURES

  • FIGURE 1. HIGH PERFORMANCE MEDICAL PLASTICS MARKET RESEARCH PROCESS
  • FIGURE 2. HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HIGH PERFORMANCE MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HIGH PERFORMANCE MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HIGH PERFORMANCE MEDICAL PLASTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HIGH PERFORMANCE MEDICAL PLASTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY ETHYLENE TETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY FLUOROPOLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY HIGH PERFORMANCE POLYAMIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY PERFLUOROALKOXY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYAMIDE-IMIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYARYLETHERKETONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYETHERIMIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYETHERKETONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY POLYPHENYLENE SULFIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY ARTIFICIAL CORNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY CHEMICAL TANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY MEDICAL EQUIPMENT & TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY MEDICAL SUPPLIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY PROSTHESIS & IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY SECRETION BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY STERILIZING BOXES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY SURGICAL THEATER LUMINARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. SINGAPORE HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. SOUTH KOREA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SOUTH KOREA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. TAIWAN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. TAIWAN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. THAILAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. THAILAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. VIETNAM HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. VIETNAM HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. DENMARK HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. DENMARK HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. EGYPT HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. EGYPT HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. FINLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. FINLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. FRANCE HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. FRANCE HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. GERMANY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. GERMANY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. ISRAEL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ISRAEL HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. ITALY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. ITALY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. NETHERLANDS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. NETHERLANDS HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. NIGERIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. NIGERIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. NORWAY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. NORWAY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. POLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. POLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. QATAR HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. QATAR HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. RUSSIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. RUSSIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SAUDI ARABIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SAUDI ARABIA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH AFRICA HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SPAIN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SPAIN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SWEDEN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SWEDEN HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SWITZERLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SWITZERLAND HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. TURKEY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TURKEY HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED ARAB EMIRATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED ARAB EMIRATES HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED KINGDOM HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED KINGDOM HIGH PERFORMANCE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. HIGH PERFORMANCE MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 115. HIGH PERFORMANCE MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2023